- ￥213 - 5570
- TargetMol
- 美国
- T1184
- 2025年07月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
零下80~20°C
- 保质期：
Powder: -20°C for 3 years In solvent: -80°C for 2 years
- 英文名：
Rivaroxaban
- 库存：
10
- 供应商：
TargetMol
- CAS号：
366789-02-8
- 规格：
5 mg/2 mg/1 mg/10 mg/500 mg/50 mg/25 mg/1 mL/100 mg/200 mg
| 规格： | 5 mg | 产品价格： | ￥527.0 |
|---|---|---|---|
| 规格： | 2 mg | 产品价格： | ￥293.0 |
| 规格： | 1 mg | 产品价格： | ￥213.0 |
| 规格： | 10 mg | 产品价格： | ￥762.0 |
| 规格： | 500 mg | 产品价格： | ￥5570.0 |
| 规格： | 50 mg | 产品价格： | ￥1580.0 |
| 规格： | 25 mg | 产品价格： | ￥1210.0 |
| 规格： | 1 mL | 产品价格： | ￥559.0 |
| 规格： | 100 mg | 产品价格： | ￥2350.0 |
| 规格： | 200 mg | 产品价格： | ￥3490.0 |
Product Introduction
Bioactivity
英文名:Rivaroxaban
描述:Rivaroxaban (BAY 59-7939) is an orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon oral administration, rivaroxaban selectively binds to both free factor Xa and factor Xa bound in the prothrombinase complex. This interferes with the conversion of prothrombin (factor II) to thrombin and eventually prevents the formation of cross-linked fibrin clots. Rivaroxaban does not affect existing thrombin levels.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Oral Direct Factor Xa Inhibitors, with Special Emphasis on Rivaroxaban
Rivaroxaban is a small-molecule, direct factor Xa inhibitor that is under investigation for the prevention and treatment of venous and arterial thrombosis. To date, oral anticoagulants have been limited largely to vitamin K antagonists
Novel Anticoagulant Therapy: Principle and Practice
(dabigatran), oral-direct factor Xa inhibitors (rivaroxaban, apixaban, YM-150, DU-176b), and tissue factor/factor VIIa complex inhibitors have been “tailor-made” to target specific procoagulant complexes and have the potential to greatly expand oral
技术资料暂无技术资料 索取技术资料
